RCKT icon

Rocket Pharmaceuticals
RCKT

Overview Fund Activity

15 hedge funds and large institutions have $52.5M invested in Rocket Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DPA
1
Devon Park Associates
$17.6M
2
RCP
2
Rho Capital Partners
New York
$15.6M
3
Jennison Associates
3
Jennison Associates
New York
$5.43M
4
Franklin Resources
4
Franklin Resources
California
$4.52M
5
PCM
5
Pentwater Capital Management
Florida
$3.79M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
DPA
1
Devon Park Associates
$17.6M 3,243,709 +3,243,709 New
RCP
2
Rho Capital Partners
New York
$15.6M 2,870,584 +2,870,584 New
Jennison Associates
3
Jennison Associates
New York
$5.43M 1,000,918 +1,000,918 New
Franklin Resources
4
Franklin Resources
California
$4.52M 833,000 +833,000 New
PCM
5
Pentwater Capital Management
Florida
$3.79M 700,000 +700,000 New
SFM
6
Sphera Funds Management
Israel
$2.17M 400,000 +400,000 New
TI
7
Telemetry Investments
New York
$1.13M 207,562 +207,562 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$1.11M 203,980 +203,980 New
SIM
9
Spark Investment Management
New York
$533K 100,100 +100,100 New
PVI
10
Pura Vida Investments
New York
$474K 87,500 +87,500 New
Morgan Stanley
11
Morgan Stanley
New York
$97K 18,059 +18,059 New
Northern Trust
12
Northern Trust
Illinois
$90K 16,661 +16,661 New
Citigroup
13
Citigroup
New York
$21K 3,800 +3,800 New
BIM
14
BlackRock Investment Management
Delaware
$6K 1,133 +1,133 New
UBS Group
15
UBS Group
Switzerland
$5K 946 +946 New